Abstract:Objective To investigate the role of insulin (INS) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) and the underlying mechanism. Methods Male C57BL/6 mice (6-8 weeks) were randomly divided into four groups (6 mice per group):control (WT), LPS, LPS+INS, and LPS+INS+ML385 (Nrf2 inhibitor) groups. Mouse model of ALI was established with intratracheal LPS instillation, and the mice were sacrificed to collect lung tissues in 12 h after modelling. HE staining was used to observe the severity of lung injury, Giemsa staining was employed to detect the inflammatory cells in bronchoalveolar lavage fluid (BALF), enzyme-linked immunosorbent assay was ultilized to measue the contents of pro-inflammatory cytokines and ferroptosis-related indicators in lung tissues, and Western blotting was applied to determine the expression of ferroptosis-related proteins. SPSS statistics 19.0 and GraphPad Prism 8 were used for statistical analysis. Student′s t test was conducted for comparison between two groups, and one-way analysis of variance was performed for comparison among multiple groups. Results Compared to the WT group, the LPS group exhibited significantly severer lung injury, more BALF inflammatory, and pro-inflammatory cytokines in lung tissues (all P<0.05). INS treatment resulted in decreased malondialdehyde and increased glutathione contents, and elevated protein levels of Nrf2 and GPX4 in lung tissues when compared with the LPS group (P<0.05). Compared with the LPS+INS group, the protein levels of Nrf2 and GPX4 in the LPS+INS+ML385 group decreased significantly (P<0.05). Conclusion Insulin alleviates ferroptosis in ALI by activating the Nrf2/GPX4 pathway, suggesting a promising therapeutic target for ALI treatment.